EUVIMED · CrossrefZeitschrift
Urologic Oncology: Seminars and Original Investigations
ISSN 1078-1439 · Elsevier BV
Neueste Artikel
PCOLCE2 inhibits BLCA progression via ACSL6-dependent ferroptosis and its transcription is suppressed by the BDH1-H3K9bhb axis
Retraction notice to “Opium Consumption and Risk of Bladder Cancer: A Case-Control Analysis” Urologic Oncology: Seminars and Original Investigations 28 (2010) 610–616
Retraction notice to “Combination Chemotherapy with Docetaxel, Estramustine and Suramin for Hormone Refractory Prostate Cancer” [Urologic Oncology: Seminars and Original Investigations 23 (2005) 93–101]
Retraction notice to “Safety and Efficacy Of Sorafenib In Patients With Castrate Resistant Prostate Cancer: A Phase II Study” [Urologic Oncology: Seminars and Original Investigations 28 (2010) 21–27]
Comparison of novel salvage therapies for BCG-unresponsive NMIBC against gemcitabine/docetaxel: A reconstructed individual patient data analysis
Adoption and perceptions of utility of the RENAL nephrometry score among fellowship-trained urologic oncologists in North America
Molecular profiling of renal mass biopsy tissue: A review of feasibility and clinical utility
Adherence to active surveillance monitoring among Medicare beneficiaries with prostate cancer
Nanoparticle delivery of phytochemicals and dietary factors for epigenetic modulation in prostate cancer
PARP inhibitor–based combinations in first-line metastatic castration-resistant prostate cancer: A meta-analysis
Quantitative core-level tumor burden and grading in MRI-targeted vs. systematic prostate biopsy: A within-patient paired analysis
Cell-surface targets for prostate cancer therapeutics
Re: Etiology of testosterone deficiency after radical prostatectomy
Neoadjuvant, adjuvant, and perioperative therapy comparisons in muscle-invasive bladder cancer: Clinical and methodological considerations for the interpretation of network meta-analytic findings
Epigenetic signatures and risk determinants in bladder cancer: Implications for diagnostic and therapeutic interventions
Clarifying cohort design in a study of GLP-1 receptor agonist use and metabolic outcomes following radical cystectomy
Geospatial correlation of industrial plastics emissions with bladder and kidney cancer burden in Ohio
Ileal conduit vs. orthotopic ileal neobladder after radical cystectomy: Systematic review and meta-analysis of long-term renal function
Comment on “optimizing radical cystectomy recovery: The role of modified ERAS in improving postoperative outcomes”
Limitations of body mass index and body fat percentage and waist-to-hip ratio in urologic cancers
Antidiabetic medications and the risk of bladder cancer in patients with diabetes mellitus: A systematic review and meta-analysis
Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world study
Predictive value of toll-like receptors, myeloid differentiation factor 88, and nuclear factor kappa-B regarding the response to Bacillus Calmette-Guérin intravesical therapy in patients with high-risk non-muscle-invasive bladder cancer: A controlled cohort clinical study
The Paris System for reporting urinary cytology in the follow-up of non-muscle-invasive bladder cancer
Automating standardization of prostate cancer biopsy and histopathology reports with privacy-preserving local large language models
Subcapsular versus total orchiectomy in advanced prostate cancer: A systematic review and meta-analysis of clinical and patient-reported outcomes
Identification and validation of TP53/p53 status as a prognostic marker in penile squamous cell carcinoma: Evidence from a cohort study and meta-analysis
Testis-sparing surgery for small testicular masses: Functional and oncological outcomes
Does size matter? A national analysis of patterns of adjuvant immunotherapy receipt and tumor size–dependent survival in pT3N0M0 clear cell renal cell carcinoma
Ipsilateral sampling maintains clinically significant cancer detection and reduces overdiagnosis in PI-RADS 4–5 lesions
Jahrgänge
2026 · 3042025 · 6272024 · 5222023 · 3062022 · 3402021 · 3762020 · 3542019 · 2702018 · 3102017 · 3742016 · 2922015 · 3232014 · 3632013 · 3352012 · 2442011 · 2032010 · 1652009 · 2592008 · 2202007 · 2002006 · 1862005 · 1792004 · 2282003 · 1712002 · 582001 · 582000 · 601998 · 321997 · 341996 · 461995 · 51
EUVIMED